Physician profile
Lindsey Graff
NPI 1073907663
$1,148.07
in general payments reported to CMS, 2019-2025
21 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $99.75 · 2021: $230 · 2022: $103 · 2023: $217 · 2024: $103 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.64 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.69 | 2019-2022 | |
| Astellas Pharma US INC | $152.56 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $91.04 | 2024-2025 | Slynd |
| Verrica Pharmaceuticals INC. | $91.02 | 2025 | Ycanth |
| Hologic Sales and Service, LLC | $77.23 | 2019-2025 | Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $58.48 | 2023 | Myfembree |
| Baxter Healthcare | $56.78 | 2025 | Tisseel |
| Therapeuticsmd, INC. | $56.46 | 2019-2021 | |
| Organon LLC | $54.45 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $53.60 | 2022 | |
| Millicent US INC | $47.24 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Dysis Medical, INC. | $38.23 | 2019 | |
| Pfizer INC. | $37.93 | 2019-2020 | |
| Amgen INC. | $28.60 | 2021 | |
| Merck Sharp & Dohme LLC | $28.40 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $22.82 | 2023 | |
| Agile Therapeutics, INC. | $17.51 | 2021 | |
| Aspira Women'S Health INC | $14.87 | 2021 | |
| Avion Pharmaceuticals | $13.89 | 2021 | |
| Coopersurgical, INC. | $13.78 | 2024 | Summit Doppler |
| Lupin INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Graff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.